Inquis Medical (@inquismedical) 's Twitter Profile
Inquis Medical

@inquismedical

ID: 1773821998432768000

linkhttps://inquismedical.com/ calendar_today29-03-2024 21:18:24

16 Tweet

15 Followers

11 Following

Inquis Medical (@inquismedical) 's Twitter Profile Photo

Congratulations to Dr. Brian Stegman and his dedicated team at CentraCare Heart & Vascular Center for successfully completing three outstanding AVENTUS cases last week. #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Congratulations to Dr. Brian Stegman and his dedicated team at CentraCare Heart & Vascular Center for successfully completing three outstanding AVENTUS cases last week. 

#PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Inquis Medical (@inquismedical) 's Twitter Profile Photo

Congratulations to Dr. Tarek Hammad and the dedicated team at University Hospitals Cleveland Medical Center for successfully completing their 9th AVENTUS case. #PulmonaryEmbolism #Thrombectomy ​ #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Congratulations to Dr. Tarek Hammad and the dedicated team at University Hospitals Cleveland Medical Center for successfully completing their 9th AVENTUS case.

#PulmonaryEmbolism #Thrombectomy ​
#InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Inquis Medical (@inquismedical) 's Twitter Profile Photo

Congratulations to Dr. Samuel Horr and the dedicated team at Centennial Medical Center in Nashville, TN, for successfully completing their 7th AVENTUS case.​ ​ #PulmonaryEmbolism #Thrombectomy ​ #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Congratulations to Dr. Samuel Horr and the dedicated team at Centennial Medical Center in Nashville, TN, for successfully completing their 7th AVENTUS case.​
 ​
#PulmonaryEmbolism #Thrombectomy ​
#InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Inquis Medical (@inquismedical) 's Twitter Profile Photo

Congratulations to Dr. David O'Connor and the dedicated team at Hackensack University Medical Center for successfully completing their 1st AVENTUS case.​ ​ #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Congratulations to Dr. David O'Connor and the dedicated team at Hackensack University Medical Center for successfully completing their 1st AVENTUS case.​
 ​
#PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Inquis Medical (@inquismedical) 's Twitter Profile Photo

Check out the latest article published in Endovascular Today highlighting the unmet needs in the (PE) thrombectomy space. Hear from leading experts Dr. Mehdi Shishehbor, Dr. Steven Abramowitz, and Dr. Nora Tabori. evtoday.com/articles/2024-… #PulmonaryEmbolism #EndovascularToday

Inquis Medical (@inquismedical) 's Twitter Profile Photo

Congratulations to Dr. Updesh Bedi, and the dedicated team at Ochsner Medical Center for successfully completing their 1st AVENTUS case.​ #PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology

Congratulations to Dr. Updesh Bedi, and the dedicated team at Ochsner Medical Center for successfully completing their 1st AVENTUS case.​

#PulmonaryEmbolism #Thrombectomy #InquisMedical #AVENTUS #Cardiology #InterventionalCardiology
Inquis Medical (@inquismedical) 's Twitter Profile Photo

We’re proud to announce that patient enrollment in the AVENTUS pivotal IDE trial evaluating the safety and efficacy of the AVENTUS Thrombectomy System for treating pulmonary embolism, has been completed. With 130 patients enrolled across more than 20 leading U.S. clinical sites,

We’re proud to announce that patient enrollment in the AVENTUS pivotal IDE trial evaluating the safety and efficacy of the AVENTUS Thrombectomy System for treating pulmonary embolism, has been completed.
With 130 patients enrolled across more than 20 leading U.S. clinical sites,
Inquis Medical (@inquismedical) 's Twitter Profile Photo

A Significant Milestone in the AVENTUS Clinical Trial! We’re excited to share that patient enrollment in our AVENTUS pivotal IDE trial is officially complete! This accomplishment is the result of collective dedication and collaboration, bringing us one step closer to

Inquis Medical (@inquismedical) 's Twitter Profile Photo

At #SCAI2025 in Washington, D.C., Dr. Jun Li will unveil the pivotal IDE trial results for the AVENTUS Thrombectomy System in treating acute intermediate-risk pulmonary embolism (PE). Conducted across over 20 U.S. sites, this pivotal study reflects a truly comprehensive,

At #SCAI2025 in Washington, D.C., Dr. Jun Li will unveil the pivotal IDE trial results for the AVENTUS Thrombectomy System in treating acute intermediate-risk pulmonary embolism (PE).

Conducted across over 20 U.S. sites, this pivotal study reflects a truly comprehensive,
Inquis Medical (@inquismedical) 's Twitter Profile Photo

In just one week at #SCAI2025 in Washington, D.C., Dr. Jun Li will present pivotal clinical data from the #AVENTUS IDE trial. This prospective, multi-center study—conducted across 22 sites and enrolling 130 patients—was designed to evaluate the safety and efficacy of the AVENTUS

Inquis Medical (@inquismedical) 's Twitter Profile Photo

Our defining moment is here!​ We’re eagerly anticipating this year’s Society for Cardiovascular Angiography & Intervention’s Scientific Sessions meeting #SCAI2025 in Washington, D.C. from May 1 to 3. Dr. Jun Li will reveal findings from the pivotal IDE trial of the #AVENTUS

MyJSCAI (@myjscai) 's Twitter Profile Photo

🚨AVENTUS Trial Results presented at #SCAI2025 🔍 Key Findings: #AVENTUS #thrombectomy system safely & effectively treats intermediate-risk #PE — improving RV function, reducing clot burden, & preserving blood ➡️doi.org/10.1016/j.jsca… Saher Sabri Samuel Horr Wissam A Jaber

🚨AVENTUS Trial Results presented at #SCAI2025

🔍 Key Findings: #AVENTUS #thrombectomy system safely & effectively treats intermediate-risk #PE — improving RV function, reducing clot burden, & preserving blood

➡️doi.org/10.1016/j.jsca… 

<a href="/saherssabri/">Saher Sabri</a> <a href="/SamHorrMD/">Samuel Horr</a> <a href="/wissamj123/">Wissam A Jaber</a>
Inquis Medical (@inquismedical) 's Twitter Profile Photo

The AVENTUS IDE trial, which evaluated the safety and efficacy of mechanical thrombectomy with autologous blood reinfusion for acute intermediate-risk pulmonary embolism is now published in JSCAI.​ In the prospective, multi-center study of 130 patients, AVENTUS met its primary

Inquis Medical (@inquismedical) 's Twitter Profile Photo

The pivotal IDE trial results for the AVENTUS Thrombectomy and Blood Filtration System have just been released. In our prospective, multi-center study, AVENTUS met its primary safety and efficacy endpoints and delivered best-in-class clinical results, significantly reducing

Inquis Medical (@inquismedical) 's Twitter Profile Photo

A heartfelt thank you to Dr. Jun Li for her presentation of the seminal #AVENTUS IDE trial results at #SCAI2025! The dedication of our National Co-PIs, Dr. Jun Li and Dr. Saher Sabri—along with the exceptional investigators, and research teams that spanned 22 U.S. sites and

Inquis Medical (@inquismedical) 's Twitter Profile Photo

Fireside chat with the AVENTUS Trial Co-Principal Investigators How is innovation reshaping pulmonary embolism (PE) treatment? Dr. Mehdi Shishehbor joined Dr. Jun Li and Dr. Saher Sabri, national co-principal investigators of the AVENTUS Trial, to discuss the trial's compelling